Postpartum haemorrhage (PPH) is a leading cause of maternal mortality worldwide, accounting for approximately one-quarter of all maternal deaths. It occurs when a woman experiences excessive bleeding after giving birth, typically within the first 24 hours. Prompt detection and intervention are crucial to prevent severe complications and save lives. In a recent breakthrough, a new wearable optical device has shown promising potential in detecting PPH, offering hope for improved maternal healthcare.
Developed by a team of researchers, this innovative device utilizes near-infrared spectroscopy (NIRS) technology to monitor changes in blood volume and oxygenation levels in real-time. By placing the device on the mother’s abdomen, it can non-invasively measure the blood flow and detect any abnormalities that may indicate PPH.
The device works by emitting near-infrared light into the tissue, which is then absorbed by the blood. The reflected light is captured by sensors in the device, allowing it to analyze the changes in light absorption and calculate the blood volume and oxygenation levels. This information is then transmitted wirelessly to a smartphone or computer for further analysis.
One of the key advantages of this wearable device is its ability to provide continuous monitoring throughout the critical postpartum period. Traditional methods of detecting PPH, such as visual inspection or measuring blood loss, often rely on subjective assessments and may not capture early signs of hemorrhage. With this new device, healthcare providers can receive real-time alerts if there are any deviations from normal blood flow or oxygenation levels, enabling them to intervene promptly.
In addition to its potential for early detection, the wearable optical device also offers convenience and ease of use. It is lightweight, portable, and can be easily worn by the mother without causing discomfort or hindering mobility. This makes it suitable for use in various healthcare settings, including low-resource settings where access to advanced medical equipment may be limited.
The researchers conducted a pilot study involving a small group of postpartum women to evaluate the device’s performance. The results were promising, with the device successfully detecting PPH in all cases where it occurred. Furthermore, it demonstrated a high level of accuracy in distinguishing between normal and abnormal blood flow patterns.
While this new wearable optical device shows great potential, further research and validation are needed before it can be widely implemented in clinical practice. Larger-scale studies involving diverse populations are necessary to ensure its effectiveness across different demographics and healthcare settings. Additionally, regulatory approvals and cost considerations will need to be addressed to make the device accessible to healthcare providers globally.
Nevertheless, the development of this wearable optical device represents a significant step forward in improving maternal healthcare, particularly in the detection and management of PPH. By providing real-time monitoring and early detection, it has the potential to save countless lives and reduce the burden of maternal mortality worldwide. With continued advancements in medical technology, we can hope for a future where PPH becomes a preventable and manageable condition, ensuring safer childbirth experiences for women everywhere.
- SEO Powered Content & PR Distribution. Get Amplified Today.
- PlatoData.Network Vertical Generative Ai. Empower Yourself. Access Here.
- PlatoAiStream. Web3 Intelligence. Knowledge Amplified. Access Here.
- PlatoESG. Carbon, CleanTech, Energy, Environment, Solar, Waste Management. Access Here.
- PlatoHealth. Biotech and Clinical Trials Intelligence. Access Here.
- Source: Plato Data Intelligence.
- Source Link: https://zephyrnet.com/wearable-optical-device-could-detect-postpartum-haemorrhage-physics-world/